1. Home
  2. ALKS vs CNX Comparison

ALKS vs CNX Comparison

Compare ALKS & CNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • CNX
  • Stock Information
  • Founded
  • ALKS 1987
  • CNX 1860
  • Country
  • ALKS Ireland
  • CNX United States
  • Employees
  • ALKS N/A
  • CNX N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • CNX Oil & Gas Production
  • Sector
  • ALKS Health Care
  • CNX Energy
  • Exchange
  • ALKS Nasdaq
  • CNX Nasdaq
  • Market Cap
  • ALKS 5.1B
  • CNX 4.6B
  • IPO Year
  • ALKS 1991
  • CNX 1999
  • Fundamental
  • Price
  • ALKS $29.05
  • CNX $28.80
  • Analyst Decision
  • ALKS Strong Buy
  • CNX Hold
  • Analyst Count
  • ALKS 13
  • CNX 13
  • Target Price
  • ALKS $40.38
  • CNX $32.08
  • AVG Volume (30 Days)
  • ALKS 2.0M
  • CNX 2.3M
  • Earning Date
  • ALKS 07-29-2025
  • CNX 07-24-2025
  • Dividend Yield
  • ALKS N/A
  • CNX N/A
  • EPS Growth
  • ALKS 21.99
  • CNX N/A
  • EPS
  • ALKS 2.08
  • CNX 0.97
  • Revenue
  • ALKS $1,505,296,000.00
  • CNX $1,813,319,000.00
  • Revenue This Year
  • ALKS N/A
  • CNX $29.36
  • Revenue Next Year
  • ALKS $3.33
  • CNX $22.80
  • P/E Ratio
  • ALKS $13.99
  • CNX $29.57
  • Revenue Growth
  • ALKS N/A
  • CNX 35.63
  • 52 Week Low
  • ALKS $25.56
  • CNX $25.88
  • 52 Week High
  • ALKS $36.45
  • CNX $41.93
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 60.08
  • CNX 33.14
  • Support Level
  • ALKS $26.07
  • CNX $28.39
  • Resistance Level
  • ALKS $28.73
  • CNX $29.41
  • Average True Range (ATR)
  • ALKS 0.87
  • CNX 0.74
  • MACD
  • ALKS 0.35
  • CNX -0.05
  • Stochastic Oscillator
  • ALKS 97.94
  • CNX 19.16

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About CNX CNX Resources Corporation

CNX Resources Corp is an independent low carbon intensity natural gas and midstream company engaged in the exploration, development, production and acquisition of natural gas properties in the Appalachian Basin. The company's operating segment include Shale and Coalbed Methane. It generates maximum revenue from the Shale segment. It also has other segment that includes nominal shallow oil and gas production.

Share on Social Networks: